Estrogen does not directly enlarge the muscles of the buttocks, but it strongly influences where your body stores fat, and the lower body is one of its preferred targets. The hormone steers fat toward the hips, thighs, and buttocks and away from the abdominal cavity, which is why women of reproductive age typically carry more subcutaneous fat in those areas than men do. How much your buttocks actually change in size depends on several factors beyond estrogen alone, including your genetics, total body fat, and the specific hormonal context involved.
How Estrogen Directs Fat to the Lower Body
Fat cells are not all the same. Those in your abdomen, hips, and thighs have different concentrations of estrogen receptors, and the type of receptor present determines how estrogen affects each depot. Research on human adipose tissue has found that one subtype, estrogen receptor beta, is present at significantly higher levels in gluteal (buttock-region) fat than in abdominal fat. One study in premenopausal women reported that gluteal subcutaneous tissue had roughly twice the beta-receptor protein content compared to abdominal tissue, while the alpha-receptor pattern was reversed, with higher levels in the abdomen.1PubMed. Estrogen receptor protein content is different in abdominal than gluteal subcutaneous adipose tissue of overweight-to-obese premenopausal women Earlier work confirmed a similar pattern: ER-beta expression in intra-abdominal fat was roughly five-fold lower in women and three-fold lower in men compared to subcutaneous fat, while certain beta isoforms were specifically elevated in gluteal tissue.2PubMed. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization
The practical upshot: when estrogen circulates through your body, it does not treat every fat depot equally. It preferentially encourages fat storage in subcutaneous tissue, particularly in the extremities and gluteofemoral region, while androgens like testosterone tend to push fat toward the visceral and abdominal areas.3PubMed Central. Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes This receptor-level difference is why estrogen’s effect on body shape is fundamentally about redistribution. Estrogen doesn’t create fat from nothing; it changes where new fat ends up when your body has a caloric surplus.
What Happens When Estrogen Drops at Menopause
Some of the clearest evidence that estrogen shapes buttock and hip fat comes from watching what happens when it disappears. During menopause, estrogen levels decline sharply, and the pattern of fat storage shifts. Fat that previously accumulated in the hips, thighs, and buttocks begins to favor the abdominal region instead.4PubMed Central. Estrogen Deficiency and the Origin of Obesity during Menopause This is not just an issue of gaining weight; it is a change in body geometry. Research tracking women across the menopausal transition has found an overall increase in fat mass with a tendency toward waist accumulation, alongside a decrease in lean mass that is especially pronounced in the lower limbs.5PubMed. Body weight and fat mass across the menopausal transition: hormonal modulators
The result is a shift from what researchers call a gynoid shape (lower-body-dominant fat) to an android shape (abdomen-dominant fat). Many women notice their waistline expanding while their hips and buttocks seem to flatten or lose volume, even if the number on the scale hasn’t changed dramatically. This redistribution is driven not by lifestyle changes alone but by the loss of estrogen’s fat-directing signal.
Evidence from Gender-Affirming Hormone Therapy
Transgender women who begin estrogen-based hormone therapy offer a natural experiment in what estrogen does to body shape when introduced into a body that previously ran primarily on testosterone. The changes can be striking. In one study of Chinese transwomen receiving gender-affirming hormone therapy, total body fat increased by about 20%, but the gains were not evenly spread. Leg fat content rose by roughly 41%, and corrected leg fat by about 51%, while visceral abdominal fat actually dropped by around 37%.6PubMed Central. Effects of gender-affirming hormone therapy on body fat: a retrospective case‒control study in Chinese transwomen That is a dramatic reshuffling: fat moved out of the belly and into the lower body.
Another study found that both oral and sublingual low-dose estradiol decreased the waist-to-hip ratio and the ratio of android to gynoid fat within just six months, indicating an early shift toward a more feminine distribution.7The Journal of Sexual Medicine. Early body composition changes in trans women on low-dose estradiol: comparing oral vs sublingual administration using dual energy absorptiometry and bioelectrical impedance analysis MRI-based research on transwomen treated with ethinyl estradiol confirmed a significant increase in all subcutaneous fat depots, with a lesser but proportional increase in visceral fat, and a notable decrease in thigh muscle area.8PubMed. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals That last detail matters: estrogen was simultaneously adding fat to the thighs and buttocks while reducing muscle volume in those same areas, so the tissue composition shifted even though the overall contour filled out.
A separate Indian study documented a more modest overall increase in subcutaneous fat (about 9%) among transwomen on hormone therapy, along with an 11% rise in visceral fat.9PubMed Central. Body composition following gender affirming hormone therapy in transgender individuals The variation between studies reflects differences in estrogen dose, duration, and the populations studied, but the directional message is consistent: exogenous estrogen pushes fat toward the lower body.
Hormone Replacement Therapy After Menopause
If estrogen loss at menopause drives fat away from the buttocks and toward the waist, does replacing it reverse the process? The evidence says it partly does, though “partly” is the operative word. A prospective study in early postmenopausal women found that continuous estrogen-progestin therapy did not prevent overall weight gain but did minimize the shift from gynoid to android fat distribution.10PubMed. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study In other words, the women on HRT still gained some weight, but their body shape changed less dramatically than the women who went without.
A study comparing treated and untreated postmenopausal women over 12 months found that the untreated group shifted toward a more central android fat pattern, while the HRT group showed no significant change in trunk or arm fat but did see a statistically significant increase in leg fat, from an average of about 7.1 kg to 8.3 kg.11The Journal of Clinical Endocrinology & Metabolism. Body Weight, Body Fat Distribution, and Hormonal Replacement Therapy in Early Postmenopausal Women That increase in lower-body fat, with stable trunk fat, is exactly what you’d expect if estrogen were protecting the gynoid fat pattern. Some HRT regimens may even help prevent overall fat mass gain and redistribution.12PubMed. Weight gain and hormone replacement therapy: are women’s fears justified?
So HRT is not a targeted buttock-enlargement tool, but it does seem to preserve the lower-body fat distribution that estrogen maintained before menopause. The gains are modest and won’t dramatically reshape anyone, but the pattern of protection is real.
Do Birth Control Pills Change Your Shape?
Many people who start hormonal contraceptives worry about gaining weight or changing body shape. The evidence here is less dramatic than the menopausal or transgender data. One study of young women using a low-dose estrogen oral contraceptive found that about 31% gained more than half a kilogram, and the gain was due to fat accumulation rather than water retention. However, the waist-to-hip ratio did not change significantly.13PubMed. Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women A separate prospective study of a different low-dose pill found no significant change in weight, body fat percentage, or fat distribution at all.14PubMed. A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet (gestodene75/EE20) on body fat
The discrepancy likely comes down to the specific formulation and dose, individual differences in metabolism, and study design. Modern oral contraceptives use much lower estrogen doses than older formulations, and the estrogen component is typically ethinyl estradiol rather than the estradiol your ovaries produce. At these doses, the hormonal signal is usually not strong enough to meaningfully redirect fat storage. If you’ve noticed your body changing after starting the pill, the cause is more likely a slight overall increase in fat or fluid retention than a targeted reshaping of your lower body.
When Estrogen Is Blocked
The flip side of the estrogen-fat story shows up in breast cancer treatment. Aromatase inhibitors, which drastically reduce estrogen production, are widely used in postmenopausal women with hormone-sensitive breast cancer. These drugs essentially create a more extreme version of the estrogen decline that occurs naturally at menopause. One study found that aromatase inhibitor therapy shifted the ratio of visceral to subcutaneous abdominal fat, with visceral fat increasing by an average of 18% while subcutaneous fat slightly decreased.15PubMed. Modification of abdominal fat distribution after aromatase inhibitor therapy in breast cancer patients visualized using 3-D computed tomography volumetry Another study documented an average increase in total fat mass of about 7% alongside a 3% decline in lean mass, with the fat gains varying by body region.16PubMed Central. Changes in body composition in early breast cancer patients treated with aromatase inhibitors
These findings reinforce the same principle from the opposite direction: when estrogen’s signal is removed, fat migrates toward the visceral and abdominal compartments and away from the subcutaneous lower-body depots. The buttocks and hips lose their preferential fat supply.
Pregnancy and Lactation as a Natural Experiment
Pregnancy pushes estrogen levels far higher than normal menstrual cycling does, and the body responds accordingly. During pregnancy, fat is deposited preferentially at the thighs, and to a lesser extent at other sites, with the high estrogen levels promoting a gynoid pattern of storage.17The Journal of Nutrition. Body Composition Changes during Lactation Are Highly Variable among Women After delivery, when estrogen levels crash and lactation begins, the pattern reverses: fat is mobilized from the trunk and thighs, and the lower estrogen environment may favor upper-body fat partitioning.
This cycle illustrates that estrogen’s effect on lower-body fat is not a one-time event but a continuous, dynamic signal. When the hormone rises, fat flows downward. When it falls, that preferential routing weakens. Many women notice their hips and buttocks filling out during pregnancy and gradually losing that fullness during breastfeeding, which tracks with what the hormonal data would predict.
Genetics Set the Boundaries
Estrogen provides the signal, but your genes determine how loud that signal gets and where exactly your receptors are concentrated. A large genetic study identified genes associated with sexually dimorphic fat distribution, finding that several variants linked to waist-to-hip ratio map within primate-specific genetic elements harboring motifs associated with fat cell development. The strongest female-specific gene identified, SNX10, turned out to be required for human fat cell differentiation and function and played a role in diet-induced fat expansion in female mice but not males.18Nature Genetics. Genetics of sexually dimorphic adipose distribution in humans
This means that two women with identical estrogen levels can have meaningfully different body shapes because their genetic variants affect how fat cells in different regions respond to estrogen’s signal. Some women naturally deposit more fat in the buttocks and hips; others store it more evenly. Estrogen is a necessary ingredient for the classic gynoid pattern, but it is not sufficient on its own. Your DNA has already drawn the blueprint; estrogen just determines how much of it gets built out.
Estrogen Also Shapes the Pelvis Itself
Fat distribution is not the only way estrogen affects the appearance of the lower body. The hormone also influences skeletal structure, particularly during puberty. The widening of the female pelvis at puberty is one of the first visible signs of sexual differentiation, and estrogen analogs have been shown to produce pelvis-widening effects in animal models. Women who are estrogen-deficient tend to develop a more narrow, male-like pelvic shape.19PubMed Central. The relationship between adolescent obesity and pelvis dimensions in adulthood: a retrospective longitudinal study Interestingly, the same study found that individuals who were obese during adolescence (and therefore had higher adipose-derived estrogen) had relatively wider pelves as adults, suggesting that the hormonal environment during growth years has lasting skeletal effects.
So estrogen contributes to buttock size through two independent channels: it widens the bony frame that the gluteal muscles and fat sit on, and it directs fat toward that region. The skeletal effects are set during development and are largely permanent, while the fat redistribution is ongoing and reversible.
Why the Body Stores Fat There in the First Place
The evolutionary reason women carry more lower-body fat than men may go beyond simple sexual dimorphism. Gluteofemoral fat is metabolically distinct from belly fat: population studies have found that higher hip and thigh fat is independently associated with a healthier lipid profile, better glucose metabolism, and lower cardiovascular risk. This fat depot also shows a more favorable pattern of hormone-like signaling molecules, with higher levels of leptin and adiponectin and lower levels of inflammatory compounds.20PubMed. Gluteofemoral body fat as a determinant of metabolic health
One hypothesis ties this to neurodevelopment. Gluteofemoral fat is rich in long-chain polyunsaturated fatty acids that are critical for fetal brain development. Researchers have proposed that the unusually high fat levels and specific deposition patterns in reproductive-age women evolved under selection pressure to support the large brains characteristic of humans.21Evolution and Human Behavior. Waist-hip ratio and cognitive ability: is gluteofemoral fat a privileged store of neurodevelopmental resources? On this view, estrogen’s role in routing fat to the buttocks and thighs is not a cosmetic side effect but a core reproductive strategy.
Estrogen Alone Versus Estrogen Plus Androgen
For people hoping that estrogen supplementation will specifically enlarge the buttocks, the reality check is that estrogen’s redistribution effects are modest in the absence of overall fat gain, and combining estrogen with androgen changes the equation further. A randomized trial in postmenopausal women compared estrogen alone to estrogen combined with methyltestosterone over 16 weeks. The estrogen-only group saw very small increases in lean mass across body regions, while the combination group actually lost about 0.9 kg of body fat and saw a decline in body fat percentage of about 7%.22The Journal of Clinical Endocrinology & Metabolism. Differential Effects of Oral Estrogen versus Oral Estrogen-Androgen Replacement Therapy on Body Composition in Postmenopausal Women Adding androgen to the mix counteracted estrogen’s fat-promoting effects, highlighting that the hormonal environment as a whole, not just estrogen in isolation, determines your body composition outcome.
This is relevant for anyone considering hormonal interventions with body shape in mind. Estrogen nudges fat toward the lower body, but the degree of change depends on total caloric balance, what other hormones are present, the specific estrogen formulation and dose, and your individual genetic sensitivity. The transgender hormone therapy data, where estrogen doses are higher and anti-androgens suppress testosterone, shows the most dramatic reshaping because both halves of the hormonal equation are being shifted simultaneously.
Why the Muscle Component Gets Overlooked
Most discussions of estrogen and buttock size focus entirely on fat, but the gluteal muscles are the largest contributor to buttock shape and projection. Estrogen does not build muscle. In fact, the MRI data from transwomen showed that estrogen therapy decreased thigh muscle area even as it increased fat in the same region.8PubMed. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals The menopausal transition data similarly shows lean mass declining in the lower limbs.5PubMed. Body weight and fat mass across the menopausal transition: hormonal modulators
If your goal is a larger, firmer-looking buttock, estrogen alone works against you on the muscle side. It adds softness and roundness through fat deposition while potentially allowing muscle mass to decline. Resistance training, particularly exercises that load the glutes heavily, remains the most effective way to build the structural volume underneath the fat layer. The people who achieve the most visible change in buttock size and shape are typically doing both: maintaining adequate estrogen signaling (through natural hormonal health or appropriate therapy) to support lower-body fat distribution, and training the gluteal muscles to provide underlying volume and lift. Neither approach alone does what both can do together.